After care navigation company Transcarent announced last week that it raised $126 million in Series D funding, CEO Glen Tullman told MedCity News that he has “no interest” in selling the company. However, an initial public offering (IPO) — when a privately owned company sells shares of stock to the public — is a possibility, he said. “I have run four public companies and have gone through three IPOs, so it’s a question I often get asked,” he said in an email. “Today, we run Transcarent like a public company, and we have a strong leadership team in place should we choose to IPO at some point in the future. … I can say with confidence that there will be great options ahead for us, and we’ll make any exit decisions for the right reasons.”
Read the full article: Glen Tullman Has ‘No Interest’ in Selling Transcarent, but IPO Is a Possibility //
Source: https://medcitynews.com/2024/05/glen-tullman-has-no-interest-in-selling-transcarent-but-ipo-is-a-possibility/